The ACR's Psoriatic Arthritis Guidelines provides comprehensive recommendations for managing active psoriatic arthritis and aims to assist clinicians and patients in making informed decisions tailored to individual situations. Test your knowledge with this quiz.
The American College of Rheumatology 2018 Psoriatic Arthritis Guidelines provides comprehensive recommendations for managing active psoriatic arthritis (PsA) in treatment-naive patients and those with ongoing activity despite treatment. The guideline addresses various treatment options, including oral small molecules, tumor necrosis factor (TNF) inhibitors, interleukin-12/23 (IL-12/23) inhibitors, IL-17 inhibitors, and Janus kinase (JAK) inhibitors.
The guideline aims to assist healthcare providers and patients in making informed decisions tailored to individual situations, emphasizing it should not restrict treatment options for patients with PsA.
Test your knowledge of PsA treatment with this quiz:
In adult patients with active PsA and a history of frequent serious infections, both oral small molecule (OSM)- and biologic treatment-naive, what is the strongly recommended initial treatment choice according to the guideline?